Public Profile

Xttrium Labs

Xttrium Labs, a leading innovator in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in advanced biopharmaceutical solutions, focusing on drug development and personalised medicine. With a commitment to scientific excellence, Xttrium Labs offers a unique portfolio of core products and services, including cutting-edge therapeutics and diagnostic tools that leverage proprietary technologies. Their emphasis on research and development has led to significant breakthroughs, positioning them as a formidable player in the industry. Recognised for their contributions to healthcare, Xttrium Labs has achieved notable milestones, including successful collaborations with major pharmaceutical companies and a growing pipeline of innovative treatments. Their dedication to improving patient outcomes continues to drive their market presence and reputation.

DitchCarbon Score

How does Xttrium Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Xttrium Labs's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Xttrium Labs's reported carbon emissions

Xttrium Labs, headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. However, without specific information from Xttrium Labs, it is unclear what their current strategies or commitments entail.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Xttrium Labs's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Xttrium Labs is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Xttrium Labs is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

TOTAL FIRE PROTECTION

US
Health Services
Updated 11 days ago

Trinity Consultants

US
Health Services
Updated 11 days ago

ALTECHNA

LT
Health Services
Updated 11 days ago

Performance Health

US
Health Services
Updated 11 days ago

Corewell Health

US
Health Services
Updated 11 days ago

Millipore OY

FI
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers